Mónica Jorge

Perioperative trastuzumab, capecitabine and oxaliplatin in patients with HER2-positive resectable gastric or gastro-oesophageal junction adenocarcinoma: NEOHX phase II trial

Fernando Rivera, Marta Izquierdo-Manuel, Pilar García‐Alfonso et al. · European Journal of Cancer · 2021 · 65 citations

Medicine, Oncology, Surgery +17

Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial

Fernando Rivera, C. Romero, Paula Jiménez‐Fonseca et al. · Cancer Chemotherapy and Pharmacology · 2019 · 64 citations · Full text

Medicine, Oncology, Pharmacology +14

Correlation of Hypertension and Proteinuria with Outcome in Elderly Bevacizumab-Treated Patients with Metastatic Colorectal Cancer

Jaime Feliú, Antonieta Salud, María José Safont et al. · PLoS ONE · 2015 · 44 citations · Full text

Medicine, Oncology, Pharmacology +13

First-line bevacizumab and capecitabine–oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study

Jaime Feliú, Antonieta Salud, María José Safont et al. · British Journal of Cancer · 2014 · 33 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Nature of drug resistance and predictors of multidrug-resistant tuberculosis among patients seen at the Philippine General Hospital, Manila, Philippines.

M T Mendoza, Anabela Gonzaga, Claudia C. Correa Roa et al. · PubMed · 1997 · 31 citations

Medicine, Pharmacology, Antimicrobial Pharmacotherapy +16